CCR9 and hepatocellular carcinoma: Similarly, hepatitis B virus (HBV) surface antigens (SHBs) increase CCR9 expression through KIAA1429-mediated m6A modification, stabilizing CCR9 mRNA and facilitating HCC progression and regorafenib resistance (77).